Healthcare >> CEO Interviews >> June 7, 2001
DR. CHRISTOPHER B. WOOD has served as the President and Chief Executive
Officer of Bioenvision Inc. since January 1999. From January 1997 to
December 1998, Dr. Wood was Chairman of Eurobiotech, Inc. From March
1994 to January 1997, Dr. Wood was a specialist surgeon in the National
Health Service, UK. From April 1979 to March 1991, Dr. Wood was a
specialist surgeon at The Royal Postgraduate Medical School, London,
England. He has more than 15 years' experience in the European
biotechnology sector. He has taken two biotechnology companies from
startup through commercialization, one of which, Medeva Plc, traded on
the London Stock Exchange and the New York Stock Exchange, and is now
wholly owned by Celltech Group Plc. Dr. Wood holds an MD from the
University of Wales School of Medicine and the Fellowship of the Royal
College of Surgeons of Edinburgh. Profile
Dr. Wood: Bioenvision is an emerging biopharmaceutical company that is
focused on oncology. We have four platform technologies from
